Myeloid cell leukemia 1 (MCL-1): Structural characteristics and application in cancer therapy-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Myeloid cell leukemia 1 (MCL-1): Structural characteristics and application in cancer therapy

Published:2021-09 Issue: Volume:187 Page:999-1018
ISSN:0141-8130
Container-title:International Journal of Biological Macromolecules
language:en
Short-container-title:International Journal of Biological Macromolecules

Author:

Mittal Pooja,Singh Sujata,Sinha Rajesh,Shrivastava Anju,Singh Archana,Singh Indrakant Kumar

Funder

Department of Health Research, India

Indian Council of Medical Research

Council of Scientific and Industrial Research, India

Publisher

Elsevier BV

Subject

Molecular Biology,General Medicine,Biochemistry,Structural Biology

Reference192 articles.

1. The Bcl-2 protein family: arbiters of cell survival;Adams;Science,1998

2. Noncanonical cell fate regulation by Bcl-2 proteins;Chong;Trends Cell Biol.,2020

3. Molecular comprehension of Mcl-1: from gene structure to cancer therapy;Senichkin;Trends Cell Biol.,2019

4. The BCL-2 arbiters of apoptosis and their growing role as cancer targets;Adams;Cell Death Differ.,2018

5. Apoptosis and cancer;Letai;Annu. Rev. Cancer Biol.,2017

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exploring Predictive and Prognostic Biomarkers in Colorectal Cancer: A Comprehensive Review;Cancers;2024-08-08

2. Construction of mirror-image RNA nanostructure for enhanced biostability and drug delivery efficiency;2024-07-17

3. Venetoclax therapy and emerging resistance mechanisms in acute myeloid leukaemia;Cell Death & Disease;2024-06-12

4. Targeting Myeloid Leukemia-1 in Cancer Therapy: Advances and Directions;Journal of Medicinal Chemistry;2024-04-10

5. Anlotinib Inhibits Cisplatin Resistance in Non-Small-Cell Lung Cancer Cells by Inhibiting MCL-1 Expression via MET/STAT3/Akt Pathway;Canadian Respiratory Journal;2024-03-04

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3